ACADEMISCH ZIEKENHUIS LEIDEN
- Country
- Netherlands
- Type
- Beneficiary
- Website
- www.lumc.nl
- Grants received
- 335
Funding record
- 335 grants on record
- €216,538,375.38 awarded in total
- 2008–2026 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
147 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- KAROLINSKA INSTITUTET
- KATHOLIEKE UNIVERSITEIT LEUVEN
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Calls from this organisation
No published calls from this organisation.
Grants received
- Role of estrogen signaling to astrocytes in the hypothalamus in the development of obesity.
- Exploring the impact of Time-Restricted Eating and Exercise interventions on Gut microbiome of patients with hepatic steatosis and obesity – TREEGut
- Chemogenetics Application and PhotoActivated ChemoTherapy to study Multidrug Resistance in Glioblastoma
- Generating a 3D Micro necroptosis induced Myocardial Infarction model
- Realizing ambulatory shock-free termination of atrial fibrillation
- Spatial Metabolic Regulation in Kidney Repair
- NEW STRATEGIES FOR THE EARLY DIAGNOSIS, RISK STRATIFICATION AND CO-MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA
- A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues
- Understanding and targeting pathogenic IgG4 responses
- Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection
- Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy
- EUROPEAN RARE DISEASES RESEARCH ALLIANCE
- SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment
- Developing a human-based stem cell model for reproductive toxicity
- Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.